GSK Agrees To $6.5M Settlement In Benefiber Labeling Class Suit
NEW YORK — A federal judge in New York on June 8 granted preliminary approval of a $6.5 million settlement in a putative class complaint accusing GSK Consumer Health Inc. of...To view the full article, register now.
Already a subscriber? Click here to view full article